|
|
||||||||
1From the Division of Gene Therapy, University of Ulm, Ulm, Germany; 2Department of Experimental Vitreo-Retinal Surgery, University of Tübingen, Tübingen, Germany; and the 3Center of Ophthalmology, Department of Vitreo-Retinal Surgery, University of Cologne, Cologne, Germany.
PURPOSE. Choroidal neovascularization plays an important role in pathogenesis of age-related macular degeneration. Induction of neovascularization by laser photocoagulation in the rat fundus is an established animal model in which the effects of new therapeutic approaches are assessed. The purpose of this study was to compare different detection methods of laser-induced neovascularization in the rat.
METHODS. Laser spots were applied to the fundus of Long-Evans rats. Ten days after, four different methods were used to detect laser-induced neovascularization: (1) high-resolution angiography with fluorescein isothiocyanate-dextran, (2) immunohistochemical visualization of platelet endothelial cell adhesion molecule (PECAM)-1, (3) visualization of intravascular lumens by peroxidase perfusion in the living rat with subsequent histologic analysis, and (4) histochemical representation of alkaline phosphatase in endothelial cells.
RESULTS. At the rim of the laser scars vessel-forming endothelial cells with intravasal dextran and peroxidase were present. Cross-sections demonstrated that these vessels originated from the retina. The center of the scars contained homogenous endothelial cells of choroidal origin, which was confirmed by immunohistochemistry and electron microscopy. In laser-treated eyes without FITC-dextran perfusion, scars showed unspecific fluorescence, making differentiation from specific FITC-dextranassociated fluorescence difficult.
CONCLUSIONS. In the rat model of laser-induced neovascularization, newly developed endothelial cells originate from the retina and the choroid. Whereas ring-like surrounding vessels come from the retina, flat endothelial cells in deeper layers are of choroidal origin or may originate from circulating endothelial precursor cells. Dextran angiography has to be regarded critically for visualizing the choriocapillaris and CNV in laser scars. PECAM-1 immunohistochemistry is best for detection and quantification of neovascularization in laser scars.
This article has been cited by other articles:
![]() |
C. Campa, I. Kasman, W. Ye, W. P. Lee, G. Fuh, and N. Ferrara Effects of an Anti-VEGF-A Monoclonal Antibody on Laser-Induced Choroidal Neovascularization in Mice: Optimizing Methods to Quantify Vascular Changes Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 1178 - 1183. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Olson, R. J. Courtney, and N. Mandava Intravitreal Infliximab and Choroidal Neovascularization in an Animal Model Arch Ophthalmol, September 1, 2007; 125(9): 1221 - 1224. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Campos, J. Amaral, S. P. Becerra, and R. N. Fariss A Novel Imaging Technique for Experimental Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5163 - 5170. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Semkova, S. Fauser, A. Lappas, N. Smyth, N. Kociok, B. Kirchhof, M. Paulsson, V. Poulaki, and A. M. Joussen Overexpression of FasL in retinal pigment epithelial cells reduces choroidal neovascularization FASEB J, August 1, 2006; 20(10): 1689 - 1691. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Imamura, S. Noda, K. Hashizume, K. Shinoda, M. Yamaguchi, S. Uchiyama, T. Shimizu, Y. Mizushima, T. Shirasawa, and K. Tsubota Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: A model of age-related macular degeneration PNAS, July 25, 2006; 103(30): 11282 - 11287. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Yeh, D. V. Bula, J. W. Miller, E. S. Gragoudas, and J. G. Arroyo Expression of Leukocyte Adhesion Molecules in Human Subfoveal Choroidal Neovascular Membranes Treated with and without Photodynamic Therapy Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2368 - 2373. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |